Mesynthes: The accidental startup
Brian Ward dusted off his tissue repair discovery amid a resurgent biomaterials market.
Mesynthes is months away from launching its regenerative tissue substitute in the US and was recently named Supreme Winner at the prestigious Wellington Gold awards. Not bad for a Kiwi startup that exists almost by accident.
Founder and chief executive Brian Ward first looked at biological substitutes for wound care and tissue repair in the 1990s while working as a veterinary surgeon, after returning from overseas and a long career with large pharma.
Read full article via Unlimited